Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to current ...
Alpha Modus Holdings, Inc. engages in creating, developing, and licensing data driven technologies to enhance consumers in-store digital experience at the point of decision in the United States. The ...
Alpha Modus Holdings, Inc. OverviewSoftware - Application / Technology Alpha Modus Holdings, Inc. engages in creating, developing, and licensing data driven technologies to enhance consumers in-store ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback